These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26846588)

  • 1. Efficacy and Safety of an Aclidinium Bromide Treatment for 12 Weeks or Longer in Patients with Moderate-To-Severe COPD: A Meta-Analysis.
    Zou Y; Xiao J; Yang DH; Li J; Chen Q
    COPD; 2016 Aug; 13(4):499-508. PubMed ID: 26846588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aclidinium bromide for stable chronic obstructive pulmonary disease.
    Ni H; Soe Z; Moe S
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD010509. PubMed ID: 25234126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of aclidinium bromide in patients with COPD: A phase 3 randomized clinical trial in a Korean population.
    Lee SH; Lee J; Yoo KH; Uh ST; Park MJ; Lee SY; Kim JY; Kim DK; Kim SJ; Lee KH; Yoo CG
    Respirology; 2015 Nov; 20(8):1222-8. PubMed ID: 26370136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I).
    Kerwin EM; D'Urzo AD; Gelb AF; Lakkis H; Garcia Gil E; Caracta CF;
    COPD; 2012 Apr; 9(2):90-101. PubMed ID: 22320148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Aclidinium/Formoterol versus Tiotropium in COPD: Results of an Indirect Treatment Comparison.
    Medic G; Lindner L; van der Weijden M; Karabis A
    Adv Ther; 2016 Mar; 33(3):379-99. PubMed ID: 26883661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis.
    Karabis A; Lindner L; Mocarski M; Huisman E; Greening A
    Int J Chron Obstruct Pulmon Dis; 2013; 8():405-23. PubMed ID: 24043936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol.
    Singh D; D'Urzo AD; Chuecos F; Muñoz A; Garcia Gil E
    Respir Res; 2017 May; 18(1):106. PubMed ID: 28558833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb study.
    Beier J; Kirsten AM; Mróz R; Segarra R; Chuecos F; Caracta C; Gil EG
    COPD; 2013 Aug; 10(4):511-22. PubMed ID: 23819698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study.
    Jones PW; Singh D; Bateman ED; Agusti A; Lamarca R; de Miquel G; Segarra R; Caracta C; Garcia Gil E
    Eur Respir J; 2012 Oct; 40(4):830-6. PubMed ID: 22441743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease.
    Jones PW; Rennard SI; Agusti A; Chanez P; Magnussen H; Fabbri L; Donohue JF; Bateman ED; Gross NJ; Lamarca R; Caracta C; Gil EG
    Respir Res; 2011 Apr; 12(1):55. PubMed ID: 21518460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACCORD COPD II: a randomized clinical trial to evaluate the 12-week efficacy and safety of twice-daily aclidinium bromide in chronic obstructive pulmonary disease patients.
    Rennard SI; Scanlon PD; Ferguson GT; Rekeda L; Maurer BT; Garcia Gil E; Caracta CF
    Clin Drug Investig; 2013 Dec; 33(12):893-904. PubMed ID: 24085591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD.
    Manoharan A; Morrison AE; Lipworth BJ
    Lung; 2016 Apr; 194(2):259-66. PubMed ID: 26758884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies.
    Wedzicha JA; Agusti A; Donaldson G; Chuecos F; Lamarca R; Garcia Gil E
    COPD; 2016 Dec; 13(6):669-676. PubMed ID: 27159613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial.
    Beeh KM; Watz H; Puente-Maestu L; de Teresa L; Jarreta D; Caracta C; Garcia Gil E; Magnussen H
    BMC Pulm Med; 2014 Dec; 14():209. PubMed ID: 25539654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease: The ASCENT-COPD Randomized Clinical Trial.
    Wise RA; Chapman KR; Scirica BM; Bhatt DL; Daoud SZ; Zetterstrand S; Reisner C; Gil EG
    JAMA; 2019 May; 321(17):1693-1701. PubMed ID: 31063575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers.
    Chapman KR; Wise RA; Scirica BM; Bhatt DL; Daoud SZ; Lythgoe D; Gil EG
    Respir Res; 2021 Oct; 22(1):272. PubMed ID: 34686204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of aclidinium bromide 400 μg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD.
    Fuhr R; Magnussen H; Sarem K; Llovera AR; Kirsten AM; Falqués M; Caracta CF; Garcia Gil E
    Chest; 2012 Mar; 141(3):745-752. PubMed ID: 21903737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of aclidinium/formoterol versus salmeterol/fluticasone: a phase 3 COPD study.
    Vogelmeier C; Paggiaro PL; Dorca J; Sliwinski P; Mallet M; Kirsten AM; Beier J; Seoane B; Segarra RM; Leselbaum A
    Eur Respir J; 2016 Oct; 48(4):1030-1039. PubMed ID: 27492833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.